These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 14669536

  • 1. [The effects of tamoxifen on the female genital tract].
    Mourits MJ, van der Zee AG, Willemse PH, Hollema H, de Vries EG.
    Ned Tijdschr Geneeskd; 2003 Nov 22; 147(47):2315-20. PubMed ID: 14669536
    [Abstract] [Full Text] [Related]

  • 2. Tamoxifen treatment and gynecologic side effects: a review.
    Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG.
    Obstet Gynecol; 2001 May 22; 97(5 Pt 2):855-66. PubMed ID: 11336777
    [Abstract] [Full Text] [Related]

  • 3. Ovarian cysts in women receiving tamoxifen for breast cancer.
    Mourits MJ, de Vries EG, Willemse PH, ten Hoor KA, Hollema H, Sluiter WJ, de Bruijn HW, van der Zee AG.
    Br J Cancer; 1999 Apr 22; 79(11-12):1761-4. PubMed ID: 10206289
    [Abstract] [Full Text] [Related]

  • 4. The effects of tamoxifen on the female genital tract.
    Senkus-Konefka E, Konefka T, Jassem J.
    Cancer Treat Rev; 2004 May 22; 30(3):291-301. PubMed ID: 15059652
    [Abstract] [Full Text] [Related]

  • 5. [Effects of raloxifene on other organs without bone: uterus].
    Nozaki M.
    Clin Calcium; 2004 Oct 22; 14(10):55-60. PubMed ID: 15577132
    [Abstract] [Full Text] [Related]

  • 6. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group.
    J Natl Cancer Inst; 2005 Mar 02; 97(5):375-84. PubMed ID: 15741574
    [Abstract] [Full Text] [Related]

  • 7. Endometrial changes with chronic tamoxifen use.
    Loret de Mola JR.
    Curr Opin Obstet Gynecol; 1997 Jun 02; 9(3):160-4. PubMed ID: 9263698
    [Abstract] [Full Text] [Related]

  • 8. [Tamoxifen: does a wider range of indications require more careful monitoring?].
    Vogel NE, ter Brugge HG, de Graaf JC, Pierik EG.
    Ned Tijdschr Geneeskd; 2001 Jun 02; 145(22):1041-3. PubMed ID: 11414162
    [Abstract] [Full Text] [Related]

  • 9. [Cancer of the endometrium caused by antiestrogens].
    Le Bouëdec G, Dauplat J.
    Rev Fr Gynecol Obstet; 1992 Jun 02; 87(6):345-8. PubMed ID: 1631476
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen and endometrial cancer: tamoxifen effects on the human female genital tract.
    Cohen CJ.
    Semin Oncol; 1997 Feb 02; 24(1 Suppl 1):S1-55-S1-64. PubMed ID: 9045317
    [Abstract] [Full Text] [Related]

  • 11. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
    Joja I, Asakawa T, Ando Y, Shiraiwa M, Shibutani O, Akaki S, Kuroda M, Mizutani Y, Kudo T, Hiraki Y.
    Radiat Med; 1998 Feb 02; 16(4):315-9. PubMed ID: 9814431
    [Abstract] [Full Text] [Related]

  • 12. Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.
    Georgopoulos NA, Adonakis GL, Fotopoulos A, Koika V, Spinos N, Saltamavros A, Keramopoulos A, Koukouras D, Decavalas G, Kourounis GS.
    Gynecol Endocrinol; 2006 Apr 02; 22(4):185-9. PubMed ID: 16723304
    [Abstract] [Full Text] [Related]

  • 13. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study.
    Rostock M, Fischer J, Mumm A, Stammwitz U, Saller R, Bartsch HH.
    Gynecol Endocrinol; 2011 Oct 02; 27(10):844-8. PubMed ID: 21231853
    [Abstract] [Full Text] [Related]

  • 14. [Additional effect of SERM: mammary gland].
    Kurebayashi J.
    Clin Calcium; 2004 Oct 02; 14(10):47-51. PubMed ID: 15577131
    [Abstract] [Full Text] [Related]

  • 15. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA, Land SR.
    Menopause; 2008 Oct 02; 15(4 Suppl):797-803. PubMed ID: 18596601
    [Abstract] [Full Text] [Related]

  • 16. ACOG committee opinion. No. 336: Tamoxifen and uterine cancer.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice.
    Obstet Gynecol; 2006 Jun 02; 107(6):1475-8. PubMed ID: 16738185
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.
    J Natl Cancer Inst; 2005 Nov 16; 97(22):1652-62. PubMed ID: 16288118
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of tamoxifen on the human female genital tract: review of the literature.
    Varras M, Polyzos D, Akrivis Ch.
    Eur J Gynaecol Oncol; 2003 Nov 16; 24(3-4):258-68. PubMed ID: 12807236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.